MELANOTAN 2 mg

ACTIVE SUBSTANCE Melanotan II

1 vial is 10 mg

What is Melanotan II?
Melanotan II (MT-II) is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). It is a cyclic heptapeptide developed to mimic the effects of α-MSH on melanogenesis (pigment production) and other physiological pathways. This product is supplied as a high-purity, lyophilized powder for research purposes only.

What does it do?
Melanotan II primarily functions by binding to melanocortin receptors (MC1R, MC3R, MC4R, and MC5R) throughout the body. Its most studied effect is the stimulation of melanocytes in the skin to produce eumelanin (a dark brown/black pigment), leading to increased skin pigmentation (tanning) without the need for UV exposure. It also influences other pathways related to appetite, libido, and energy metabolism.

How is it used?
This product is designed for in-vitro (laboratory) research only. It is not for human or animal consumption. For experimental use, it must be reconstituted with an appropriate sterile solvent, such as bacteriostatic water. Application methods are defined by specific research protocols. Dosage, concentration, and handling procedures must be established and followed in accordance with strict laboratory safety standards.

Potential Benefits (in a research context):

• Induction of Pigmentation: The primary research focus is its potent ability to stimulate eumelanin production, useful for studies on skin biology and photoprotection.

• Appetite Modulation: Acts on central melanocortin receptors (MC4R) involved in the regulation of food intake, making it a compound of interest in metabolic studies.

• Libido and Sexual Function Research: Influences pathways related to sexual arousal and function via central nervous system receptors.

• Potential Neuroprotective Research: The melanocortin system is implicated in inflammatory and neuroprotective processes.

Possible Side Effects (research observations):
Based on scientific literature and studies, the following effects have been noted or are theoretically associated with melanocortin receptor activation:

• Common/Observed: Nausea, facial flushing, spontaneous yawning, and transient appetite suppression.

• Skin-Related: Darkening of existing moles and freckles, generalized skin darkening, and potential for uneven pigmentation.

• Systemic Effects: Increased libido, fatigue, and involuntary stretching.

• Important Note: Long-term safety data is limited. A concerning potential risk is the theoretical stimulation of melanocyte proliferation, which is a subject of ongoing scientific investigation.